chronic
viral
infect
occur
host
fail
mount
effect
immun
respons
clear
viru
mous
hepat
viru
type
appear
excel
model
studi
relationship
viralinduc
immunodefici
chronic
diseas
develop
x
aj
fl
mice
surviv
acut
hepat
develop
chronic
diseas
character
tand
bcell
immunodefici
viral
persist
variou
organ
includ
brain
spleen
thymu
death
within
month
postinfect
pi
report
tor
bcell
defici
observ
chronic
infect
x
aj
mice
partial
total
thwart
adopt
transfer
andor
b
cell
day
pi
mice
surviv
acut
phase
diseas
adopt
transfer
syngen
andor
allow
partial
restor
tcell
defici
character
thymic
atrophi
decreas
splenic
cell
thymocyt
subpopul
bcell
immunodefici
defin
decreas
splenic
b
cell
well
bone
marrow
preband
bcell
compart
occurr
abnorm
larger
form
bone
marrow
preb
b
cell
partial
thwart
bcell
treatment
splenic
b
cell
bone
marrow
bcell
compart
respect
return
partial
total
normal
valu
wherea
prebcel
compart
remain
deplet
infect
mice
treat
b
cell
level
immunoglobulin
class
return
normal
valu
chronic
infect
mice
treat
combin
cell
tandor
bcell
treatment
howev
suffici
thwart
process
chronic
diseas
favour
surviv
mice
month
pi
serotyp
appear
excel
model
studi
relationship
viralinduc
immunodefici
develop
chronic
diseas
sinc
humor
cellular
immunodefici
occur
chronic
mice
suscept
mice
develop
acut
hepat
die
within
three
day
infect
virusresist
aj
mice
develop
subclin
infect
viral
clearanc
occur
within
day
postinfect
pi
mice
result
crossbreed
suscept
resist
aj
mice
x
aj
show
partial
resist
acut
diseas
surviv
anim
develop
chronic
diseas
character
wast
syndrom
includ
weight
loss
alopecia
oili
hair
later
stage
mice
develop
incoordin
hindlimb
paralysi
eventu
die
within
three
month
previous
observ
signific
decreas
thymocyt
splenic
cell
macrophag
chronic
infect
x
aj
fl
low
antibodi
titr
viru
mostli
immunoglobulin
igm
found
day
spite
product
antibodi
immunoglobulin
type
gradual
decreas
first
three
month
follow
return
normal
chronic
viral
infect
variou
organ
includ
central
nervou
system
cn
usual
repres
complic
acut
system
diseas
infect
persist
host
immun
system
fail
clear
viru
coronaviru
infect
interest
model
analys
mechan
involv
immunemedi
viral
persist
lead
chronic
neurolog
diseas
coronavirus
ubiquit
pathogen
mous
coloni
known
induc
variou
patholog
hepat
enter
acut
chronic
neurolog
diseas
surviv
anim
human
coronavirus
lead
upper
respiratori
tract
pathogen
associ
gastroenter
also
isol
multipl
sclerosi
function
cellular
immunodefici
report
virul
mous
hepat
viru
type
mhvjhminfect
valu
paralys
primari
secondari
antibodi
respons
also
markedli
diminish
paralys
nonparalys
mice
splenic
b
cell
deplet
earli
hr
pi
maintain
low
level
three
month
death
mice
defici
result
thymic
deplet
tcell
subpopul
b
lymphocyt
bone
marrow
mice
addit
abnorm
form
preb
b
cell
lead
cell
lysi
gener
chronic
phase
diseas
virus
occasion
isol
brain
liver
spleen
lymph
node
chronic
infect
consequ
cellular
humor
immunodefici
observ
chronic
infect
x
aj
fl
mice
result
primarili
deplet
tand
bcell
subpopul
lymphoid
organ
acut
phase
diseas
decreas
andor
b
cell
may
favour
viral
persist
abrog
tcelldepend
immun
mechan
involv
viral
elimin
process
thu
lead
develop
chronic
diseas
persist
immunodefici
report
boespflug
et
use
cyclosporin
wellknown
immunomodul
agent
increas
percentag
death
acut
phase
diseas
administ
first
week
infect
inform
respect
role
cell
bcell
deplet
process
chronic
diseas
postul
therefor
adopt
transfer
syngen
b
cell
x
aj
fl
mice
surviv
acut
phase
diseas
may
thwart
tor
bcell
immunodefici
report
tcell
defici
level
immunoglobulin
partial
total
restor
administr
wherea
bcell
treatment
suffici
improv
level
bone
marrow
splenic
b
cell
hand
tandor
bcell
treatment
favor
surviv
chronic
infect
mice
month
pi
x
aj
fl
mice
purchas
jackson
laboratori
bar
harbor
use
anim
test
presenc
antimhv
antibodi
enzymelink
immunosorb
assay
elisa
use
prepar
antigen
experi
anim
hous
steril
atmospher
forma
scientif
marietta
oh
cell
cell
continu
mous
fibroblast
cell
line
grown
eagl
minim
essenti
medium
mem
glutamin
fetal
calf
serum
fc
antibiot
penicillin
uml
streptomycin
mgml
gibco
laboratori
grand
island
ny
cell
use
propag
titrat
virus
lymphoid
cell
obtain
group
three
mice
mice
kill
cervic
disloc
spleen
thymu
femur
collect
nonadher
splenic
cell
collect
accord
previous
describ
method
thymus
teas
apart
hank
balanc
salt
solut
hbss
fc
room
temperatur
use
needl
femor
shaft
flush
four
time
ml
cold
supplement
fc
larg
particl
remov
sediment
cushion
ml
fc
min
cell
suspens
centrifug
resuspend
ml
supplement
fc
cell
prepar
electron
count
coulter
counter
coulter
electron
hialeah
fl
cell
viabil
rang
assay
trypan
blue
exclus
test
pathogen
clone
substrain
produc
cell
viru
nonpathogen
variant
isol
chronic
infect
yac
cell
induc
protect
immun
respons
challeng
viru
virus
passag
cell
use
pathogen
properti
verifi
regularli
tand
bcell
purif
procedur
tand
bcell
purif
done
pan
accord
wysocki
sato
method
modif
purif
adher
monocyt
remov
incub
thymic
bone
marrow
cell
suspens
supplement
fc
respect
petri
dish
hr
incub
dish
thoroughli
wash
hbss
nonadher
cell
suspens
cellsml
pipet
anti
u
chain
jackson
immunoresearch
mississauga
ontario
canada
coat
plastic
dish
incub
twice
room
temperatur
min
time
nonadher
cell
aspir
dish
remain
adher
cell
layer
wash
four
time
camgfre
phosphatebuff
salin
pb
scrape
free
policeman
immunofluoresc
examin
reveal
final
cell
popul
contain
around
thi
surfac
u
sy
cell
respect
cell
purifi
cytotox
antibodi
respect
presenc
rabbit
complement
c
cedarlan
hornbi
ontario
canada
adher
cell
scrape
centrifug
resuspend
medium
equal
volum
antibodi
ad
follow
incub
hr
cell
centrifug
resuspend
yl
optim
dilut
c
incub
hr
cell
wash
medium
centrifug
resuspend
concentr
x
ml
immunofluoresc
examin
reveal
final
cell
popul
contain
around
cell
contain
b
lymphocyt
adopt
transfer
lymphoid
cell
x
aj
fl
mice
inject
ip
mockinfect
mice
receiv
similar
volum
pb
day
pi
mice
surviv
acut
phase
diseas
mockinfect
mice
separ
group
three
group
iv
inject
x
cell
one
follow
cell
suspens
b
cell
alon
combin
combin
b
cell
control
group
mice
infect
mockinfect
receiv
similar
volum
variou
time
posttreat
day
group
three
mice
kill
cervic
disloc
follow
paramet
record
surviv
rate
percentag
splenic
b
cell
percentag
absolut
number
diamet
bone
marrow
preb
b
cell
percentag
absolut
number
thymic
tcell
subpopul
determin
concentr
immunoglobulin
class
iggl
igm
iga
use
elisa
test
biorad
laboratori
richmond
va
express
percentag
standard
antibodi
solut
tor
bcell
label
detect
splenic
b
lymphocyt
direct
immunofluoresc
assay
fluorescein
isothiocyan
fitc
antithi
mile
scientif
napiervil
il
antip
chain
antibodi
kirkegaard
perri
laboratori
gaithersburg
md
perform
cytocentrifug
cell
prepar
tor
bcell
subpopul
subsequ
identifi
doubl
immunofluoresc
label
doubl
label
pchain
immunofluoresc
label
perform
describ
park
osmond
briefli
bone
marrow
sampl
x
nucleat
cellsml
suspens
incub
min
ice
optim
dilut
fitc
antipchain
cappel
biochem
malvern
pa
sp
label
cell
wash
twice
centrifug
fc
min
cell
resuspend
pb
bovin
serum
albumin
bsa
cytocentrifug
fix
acet
acidmethanol
solut
cytoplasm
p
cii
chain
label
optim
dilut
tetramethylrhodamin
isothiocyan
tritc
conjug
anti
chain
antibodi
cappel
biochem
cell
spot
incub
hr
room
temperatur
humidifi
chamber
wash
four
time
mount
describ
doubl
label
pchain
bone
marrow
sampl
x
nucleat
cellsml
supens
incub
rat
monoclon
antibodi
mab
obtain
dr
dg
osmond
depart
anatomi
mcgill
univers
montreal
quebec
canada
min
ice
wash
optim
dilut
fitc
antirat
igg
cappel
biochem
ad
cell
cell
wash
twice
centrifug
fc
cell
resuspend
pb
bsa
cytocentrifug
fix
acet
acidmethanol
solut
cyichain
label
optim
dilut
tritcconjug
antip
chain
antibodi
cappel
biochem
doubl
label
thymic
cell
incub
fitc
rat
mab
dimens
laboratori
missisauga
ontario
canada
min
wash
resuspend
pl
fc
mous
mab
dimens
laboratori
ad
cell
suspens
incub
anoth
min
tritc
antimous
igg
antiserum
cappel
biomed
malvern
pa
ad
incub
cytocentrifug
wash
fix
kept
overnight
pb
slide
mount
slide
mount
medium
contain
glycerol
pb
ph
pphenylenediamin
fisher
scientif
co
montreal
quebec
canada
fluoresc
microscop
leitz
dialux
midland
ontario
canada
equip
mercuri
lamp
phase
contrast
optic
use
slide
examin
cp
suand
cji
b
lineag
subpopul
diamet
least
cell
blineag
subpopul
measur
use
calibr
micromet
scale
percentag
label
cell
determin
count
total
cell
absolut
number
calcul
percentag
posit
label
cell
total
bone
marrow
thymu
count
statist
analysi
surviv
rate
group
treat
mice
perform
use
test
percentag
absolut
number
evalu
wilcoxon
mannwhitney
utest
student
ttest
respect
surviv
rate
chronic
infect
x
aj
mice
treat
b
cell
alon
combin
surviv
rate
analysi
infect
x
aj
fi
mice
indic
mice
surviv
acut
phase
diseas
measur
day
pi
neurolog
sign
howev
gradual
occur
mice
within
next
two
week
day
fig
determin
protect
role
lymphoid
cell
develop
chronic
diseas
group
mice
surviv
acut
phase
diseas
intraven
iv
inject
thymocyt
splenic
lymphoid
cell
collect
mice
viru
lymphoid
organ
collect
day
pi
nonimmun
mice
day
postinfect
observ
thymocyt
splenic
cell
immun
well
nonimmun
mice
protect
chronic
infect
mice
occurr
paralysi
death
month
infect
result
shown
result
indic
adopt
transfer
syngen
lymphoid
cell
nonimmun
mice
effici
thwart
onset
chronic
diseas
suggest
cell
may
suffici
compens
tor
bcell
loss
occur
acut
phase
diseas
determin
role
b
cell
protect
chronic
diseas
develop
analys
surviv
rate
occurr
paralysi
group
surviv
mice
treat
b
cell
alon
combin
tabl
remain
smaller
mockinfect
mice
percentag
cell
transient
increas
week
follow
adopt
transfer
alon
combin
fig
p
spite
increas
thymocyt
level
remain
lower
mockinfect
mice
thymocyt
subpopul
similarli
increas
combin
without
bcelltreat
mice
reflect
reappear
normal
lymphopoiesi
result
shown
figur
show
bcell
compart
return
normal
valu
month
administr
b
cell
alon
combin
cell
p
treatment
test
howev
alter
prebcel
defici
disturb
probcel
compart
seen
bone
marrow
infectedtr
mice
well
ofa
infect
mice
treat
tor
bcell
popul
result
shown
result
suggest
bcell
matur
process
complet
reestablish
spite
increas
bone
marrow
b
cell
previous
report
preb
b
cell
permiss
product
viral
replic
lead
gener
typic
larger
form
cell
lead
cell
lysi
verifi
blineag
cell
produc
treat
mice
still
contain
virusinduc
larger
cell
analys
cell
diamet
distribut
b
fig
preb
fig
cell
abnorm
larger
form
b
cell
seen
infect
mice
mm
strongli
decreas
mice
treat
b
cell
b
cell
cell
wherea
effect
seen
tcell
treatment
alon
rare
larger
cell
howev
still
present
mice
treat
b
cell
without
cell
hand
larger
form
preb
cell
persist
treat
mice
larger
cell
found
probcel
popul
untreatedinfect
treatedinfect
mice
result
shown
effect
adopt
transfer
b
cell
alon
combin
immunoglobulin
class
level
chronic
infect
x
aj
mice
previous
report
humor
immunodefici
occur
infect
x
aj
fl
mice
character
decreas
immunoglobulin
ig
class
spite
product
verifi
adopt
transfer
b
cell
restor
abil
mice
produc
immunoglobulin
level
igg
iga
analys
mockinfect
untreatedinfect
treatedinfect
mice
variou
time
posttreat
figur
show
treatment
transient
increas
ig
level
wherea
decreas
treat
mice
combin
cell
howev
restor
ig
level
normal
valu
day
treatment
adopt
transfer
b
cell
howev
prevent
immunoglobulin
defici
addit
immunoglobulin
level
increas
cell
ad
bcell
prepar
present
paper
shown
g
variou
time
pt
group
three
mice
kill
bone
marrow
collect
bone
marrow
cell
electron
count
doublelabel
fitc
antisi
chain
tritccu
chain
analys
diamet
least
cell
measur
use
calibr
micromet
scale
standard
deviat
partial
restor
tcell
popul
normal
valu
defici
character
thymic
atrophi
decreas
splenic
cell
thymocyt
subpopul
bcell
immunodefici
defin
decreas
splenic
b
cell
bone
marrow
preband
bcell
compart
occurr
abnorm
larger
form
bone
marrow
preb
b
cell
partial
correct
bcell
treatment
splenic
b
cell
bone
marrow
bcell
compart
return
partial
total
respect
normal
level
wherea
prebcel
compart
remain
deplet
infectedtr
mice
level
immunoglobulin
class
return
normal
valu
chronic
infect
mice
treat
combin
cell
tandor
bcell
treatment
howev
suffici
prevent
chronic
diseas
allow
mice
surviv
month
pi
work
mainli
show
administr
b
cell
naiv
syngen
mice
immun
mice
suffici
prevent
onset
chronic
viral
diseas
suggest
decreas
tor
bcell
subpopul
first
day
pi
play
major
role
occurr
chronic
diseas
rather
inabl
residu
cell
mount
immun
respons
leray
et
al
observ
tcell
function
residu
lymphocyt
normal
cell
b
cell
macrophag
origin
paralys
mice
abil
fulli
reconstitut
immun
respons
lethal
irradi
syngen
anim
shown
adopt
transfer
day
pi
variou
blackwel
scienc
ltd
immunolog
bcell
subpopul
restor
partial
total
cellular
immunodefici
thymu
spleen
bone
marrow
cell
compart
dupuy
et
al
report
irradi
mice
protect
acut
infect
adopt
transfer
splenic
cell
bone
marrow
cell
periton
macrophag
suggest
diseas
may
thwart
effici
immunemedi
viral
clearanc
mechan
postul
viral
persist
may
relat
loss
b
cell
inabl
chronic
infect
mice
produc
new
matur
cell
thymic
destruct
regener
normal
bone
marrow
b
cell
chronic
diseas
adopt
transfer
cell
popul
crucial
time
develop
chronic
diseas
day
pi
may
allow
compens
cell
loss
gradual
favour
activ
immunemedi
viral
clearanc
mechan
chronic
diseas
induc
x
aj
fl
mice
character
acut
phase
subleth
hepat
occur
howev
neuropatholog
lesion
found
day
pi
consist
import
mening
infiltr
polymorphonuclear
mononuclear
cell
well
perivascular
infiltr
mononuclear
cell
day
pi
infiltr
contain
small
lymphocyt
plasmocyt
macrophag
time
diffus
mening
infiltr
progress
decreas
inflammatori
lesion
diseappear
inflammatori
respons
normal
disappear
viral
clearanc
brain
viral
persist
howev
associ
pathogen
process
chronic
diseas
indic
failur
immunemedi
viru
elimin
immunodefici
occur
soon
hr
pi
maintain
death
anim
may
explain
disappear
inflammatori
cell
brain
day
pi
splenic
deplet
b
cell
follow
acut
phase
diseas
induc
x
aj
mice
may
result
direct
lytic
effect
viral
replic
inabl
thymu
bone
marrow
produc
matur
b
cell
previous
report
b
cell
permiss
viral
replic
cell
thymic
atrophi
mice
primarili
result
deplet
thymocyt
subpopul
without
regard
cell
matur
state
accumul
data
show
import
factor
involv
differenti
matur
cell
direct
contact
thymocyt
nonlymphoid
thymic
constitu
previous
report
thymic
stromal
cell
x
aj
fl
mice
permiss
viral
replic
lead
cell
lysi
thymic
atrophi
reflect
disappear
stromal
cell
involv
thymocyt
matur
process
addit
loss
normal
thymic
architectur
observ
infect
mice
expect
higher
level
splenic
thymic
cell
follow
adopt
transfer
combin
x
aj
mice
result
partial
repair
thymic
architectur
includ
thymic
stromal
cell
therebi
allow
occurr
normal
lymphopoiesi
explan
suppos
infecti
viru
clear
mice
andor
newli
form
stromal
cell
permiss
viral
replic
first
hypothesi
agreement
fact
infecti
viral
particl
normal
detect
thymu
spleen
brain
chronic
infect
detect
vitro
except
brain
possibl
adopt
transfer
could
suffici
clear
residu
infecti
virus
mice
sussman
et
demonstr
clearanc
neurotrop
mhvjhm
strain
cn
acut
infect
mice
control
cell
act
helper
cell
recogn
viral
antigen
cell
surfac
sinc
deplet
cell
occur
earli
hr
pi
x
aj
fl
mice
immunemedi
viral
clearanc
mechan
impair
favour
viral
persist
adopt
transfer
permit
suffici
restor
level
splenic
thymic
tcell
subpopul
involv
viral
clearanc
howev
treatment
alon
caus
recoveri
long
period
time
seen
two
cell
popul
given
togeth
suggest
infecti
virus
still
produc
even
low
titr
site
protect
immun
cell
brain
observ
inflammatori
cell
transient
increas
brain
treat
mice
result
shown
recent
report
co
blackwel
scienc
ltd
immunolog
major
lymphocyt
enter
mhvjhminfect
cn
cours
infect
prime
cell
neither
prolifer
ex
vivo
stimul
prolifer
viral
antigen
mitogen
vitro
wherea
lymphocyt
lymph
node
anim
reveal
strong
prolif
respons
addit
cell
subset
secret
interferoni
play
import
role
prevent
neurolog
diseas
progress
persist
mhvjhminfect
inhibit
viral
replic
hand
cytotox
cell
found
cn
mice
presenc
prevent
demyelin
process
cell
effici
reduc
viral
replic
ependym
cell
astrocyt
microglia
oligodendrocyt
postul
adopt
transfer
x
aj
fl
mice
may
allow
restor
inflammatori
cell
respons
brain
favour
immunemedi
viral
clearanc
mechan
spite
partial
effici
alon
viral
replic
may
delay
permit
transient
recoveri
tcell
subset
lymphoid
organ
seen
thymu
spleen
hand
humor
immunodefici
character
decreas
immunoglobulin
class
thwart
adopt
transfer
administr
b
cell
result
indic
hypoglobulinaemia
due
tcell
immunodefici
occur
blackwel
scienc
ltd
immunolog
first
day
pi
caus
function
depress
b
cell
leray
et
al
previous
observ
chronic
infect
mice
mount
immun
respons
tdepend
tindepend
result
show
restor
higher
level
splenic
thymic
cell
permit
product
immunoglobulin
class
longer
period
time
seen
transfer
cell
immunoglobulin
class
howev
decreas
administr
cell
suggest
either
suppresssor
cell
present
cell
prepar
cell
essenti
immunoglobulin
product
stimul
sinc
residu
b
cell
remain
function
chronic
infect
postul
transfer
stimul
b
cell
produc
immunoglobulin
transient
product
antibodi
howev
may
explain
permiss
preb
b
cell
viral
replic
lead
cell
lysi
previous
report
cytoimmunotherapi
approach
use
work
suggest
host
may
thwart
virusinduc
chronic
diseas
one
immun
mechan
work
progress
understand
mechan
involv
protect
effect
tor
bcell
subpopul
chronic
neurolog
diseas
